FCI K. Albin Johansson Research Professor Johanna Ivaska - UTU Research Portal

Johanna Ivaska
FCI K. Albin Johansson Research Professor

- ,
InFLAMES Flagship (Faculty of Medicine)
- ,
Turku Bioscience Centre (Independent units)
- Professor,
Department of Life Technologies (Faculty of Technology)

joivaska@utu.fi

+358 29 450 2260

+358 40 502 0812

Tykistökatu 6

Turku

: https://orcid.org/0000-0002-6295-6556

7 of 7

Vimentin regulates EMT induction and migration by governing Axl expression in breast cancer. (2011)
- Oncogene
Vuoriluoto Karoliina, Haugen halvard, Kiviluoto santeri, Mpindi john-patrik, Nevo Jonna, Gjerdrum C, Tiron Crina, Lorens James
A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-2a as first line treatment in metastatic melanoma (2010)
- Melanoma Research
Vihinen P P, Hernberg M, Vuoristo M-S, Tyynelä K, Laukka M, Lundin J, Ivaska J, Pyrhönen S
Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase (2010)
- BMC Cancer
Mattila E, Marttila H, Sahlberg N, Kohonen P, Tahtinen S, Halonen P, Perala M, Ivaska J
Interplay between cell adhesion and growth factor receptors: from the plasma membrane to the endosomes (2010)
- Cell and Tissue Research
Ivaska J, Heino J
Mammary-derived growth inhibitor (MDGI) interacts with integrin alpha-subunits and suppresses integrin activity and invasion (2010)
- Oncogene
Nevo J, Mai A, Tuomi S, Pellinen T, Pentikainen OT, Heikkila P, Lundin J, Joensuu H, Bono P, Ivaska J
PtdIns(3,4,5)P-3 is a regulator of myosin-X localization and filopodia formation (2010)
- Journal of Cell Science
Plantard L, Arjonen A, Lock JG, Nurani G, Ivaska J, Stromblad S
Smart targeting of EGFR in lung cancer (2010)
- Pharmacogenomics
Kermorgant S, NEVO J, IVASKA J
CIP2A is associated with human breast cancer aggressivity (2009)
- Clinical Cancer Research
Côme C, Laine A, Chanrion M, Edgren H, Mattila E, Liu X, Jonkers J, Ivaska J, Isola J, Darbon JM, Kallioniemi O, Thézenas S, Westermarck J
Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance (2009)
- Clinical Cancer Research
Nevo J, Mattila E, Pellinen T, Yamamoto DL, Sara H, Iljin K, Kallioniemi O, Bono P, Heikkilä P, Joensuu H, Wärri A, Ivaska J
PKCepsilon regulation of an alpha5 integrin-ZO-1 complex controls lamellae formation in migrating cancer cells (2009)
- Science Signaling
Tuomi S, Mai A, Nevo J, Laine JO, Vilkki V, Ohman TJ, Gahmberg CG, Parker PJ, Ivaska J
SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin (2009)
- Nature Cell Biology
Brandt DT, Baarlink C, Kitzing TM, Kremmer E, Ivaska J, Nollau P, Grosse R
Cross-talk between integrins alpha1beta1 and alpha2beta1 in renal epithelial cells (2008)
- Experimental Cell Research
Abair TD, Sundaramoorthy M, Chen D, Heino J, Ivaska J, Hudson BG, Sanders CR, Pozzi A, Zent R
Integrin trafficking regulated by Rab21 is necessary for cytokinesis (2008)
- Developmental Cell
Pellinen T, Tuomi S, Arjonen A, Wolf M, Edgren H, Meyer H, Grosse R, Kitzing T, Rantala JK, Kallioniemi O, Fässler R, Kallio M, Ivaska J
Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen (2008)
- Experimental Cell Research
Vuoriluoto K, Jokinen J, Kallio K, Salmivirta M, Heino J, Ivaska J
The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling (2008)
- Journal of Cell Science
Mattila E, Auvinen K, Salmi M, Ivaska J